Schroder Ventures
Europe, England, United Kingdom, London'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
Schroders is a global asset manager with £343.8 billion of assets under management and offices in 27 countries.
Investor Profile
Schroder Ventures has made 37 investments, with 1 in the past 12 months and 30% as lead.
Stage Focus
- Series B (27%)
- Series C (22%)
- Series A (22%)
- Series Unknown (14%)
- Post Ipo Equity (5%)
- Series D (5%)
- Private Equity (3%)
- Series E (3%)
Country Focus
- United States (76%)
- United Kingdom (14%)
- Germany (5%)
- Singapore (3%)
'/%3e%3cuse xlink:href='%23a' transform='translate(288.889 -214.211)'/%3e%3cuse xlink:href='%23a' transform='translate(108 342.749)'/%3e%3cuse xlink:href='%23a' transform='translate(469.189 342.749)'/%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Pharmaceutical
- Medical Device
- Information Technology
- Therapeutics
- Software
- Oncology
- Biopharma
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
